Long-term safety and efficacy profile of simvastatin
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (11) , 1127-1131
- https://doi.org/10.1016/0002-9149(91)90182-k
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Simvastatin: A New HMG CoA Reductase InhibitorCardiovascular Drug Reviews, 1990
- Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial HypercholesterolemiaArchives of internal medicine (1960), 1990
- Simvastatin: The clinical profileThe American Journal of Medicine, 1989
- Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme a reductase inhibitorsThe American Journal of Medicine, 1989
- Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)The American Journal of Cardiology, 1989
- Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1988
- HMG CoA Reductase InhibitorsDrugs, 1988
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Estimating incidence from age‐specific prevalence for irreversible diseases with differential mortalityStatistics in Medicine, 1986
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986